dabigatran and Cerebral Infarction, Middle Cerebral Artery
dabigatran has been researched along with Cerebral Infarction, Middle Cerebral Artery in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (90.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hu, MH; Wang, V; Wu, BC | 1 |
Alvarez Bravo, G; Carvalho Monteiro, G; López Zuazo, I; Orts Castro, E | 1 |
Aoki, J; Kanamaru, T; Kimura, K; Matsumoto, N; Mishina, M; Nishiyama, Y; Nito, C; Okubo, S; Sakamoto, Y; Sekine, T; Shimoyama, T; Suda, S; Suzuki, K | 1 |
Hayama, M; Inoue, H; Mio, T; Wada, H | 1 |
Bolbrinker, J; Douros, A; Ebinger, M; Kreutz, R; Schlemm, L | 1 |
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A | 1 |
Braemswig, TB; Eschenfelder, CC; Nolte, CH | 1 |
Chiu, L; Chong, CA | 1 |
Conners, JJ; Lee, VH; Prabhakaran, S | 1 |
El Khoury, R; Lopez, G; Misra, V; Sangha, N | 1 |
Other Studies
10 other study(ies) available for dabigatran and Cerebral Infarction, Middle Cerebral Artery
Article | Year |
---|---|
The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Carotid Artery Thrombosis; Carotid Artery, Internal; Dabigatran; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Middle Aged; Plaque, Atherosclerotic; Sigmoid Neoplasms; Thrombolytic Therapy; Tissue Plasminogen Activator | 2020 |
Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation; Dabigatran; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Angiography; Dabigatran; Diffusion Magnetic Resonance Imaging; Female; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Logistic Models; Magnetic Resonance Angiography; Male; Multivariate Analysis; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles; Warfarin | 2018 |
Massive haemoptysis following dabigatran administration in a patient with bronchiectasis.
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bronchial Arteries; Bronchiectasis; Dabigatran; Embolization, Therapeutic; Female; Hemoptysis; Humans; Infarction, Middle Cerebral Artery; Radiography | 2014 |
Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.
Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome | 2014 |
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator | 2016 |
Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Aphasia; Atrial Fibrillation; Carotid Stenosis; Dabigatran; Emergencies; Emergency Service, Hospital; Endarterectomy, Carotid; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Spinal Puncture; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Dabigatran and acute stroke thrombolysis.
Topics: Acute Disease; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Contraindications; Dabigatran; Drug Administration Schedule; Female; Humans; Infarction, Middle Cerebral Artery; Pyridines; Thrombolytic Therapy | 2010 |
Intravenous thrombolysis in a stroke patient taking dabigatran.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Angiography; Dabigatran; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Topics: Angiography, Digital Subtraction; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Angiography; Dabigatran; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Perfusion Imaging; Thrombin Time; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2012 |